Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Sees Large Growth in Short Interest

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 40,400 shares, a growth of 124.4% from the January 15th total of 18,000 shares. Currently, 2.4% of the company’s stock are sold short. Based on an average daily trading volume, of 47,100 shares, the short-interest ratio is presently 0.9 days.

Creative Medical Technology Price Performance

Shares of Creative Medical Technology stock opened at $4.74 on Friday. The business has a 50-day simple moving average of $2.66 and a 200 day simple moving average of $3.07. The firm has a market capitalization of $8.29 million, a price-to-earnings ratio of -1.25 and a beta of 1.85. Creative Medical Technology has a one year low of $1.96 and a one year high of $10.28.

Institutional Trading of Creative Medical Technology

A hedge fund recently bought a new stake in Creative Medical Technology stock. Geode Capital Management LLC bought a new position in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 10,308 shares of the company’s stock, valued at approximately $25,000. Geode Capital Management LLC owned about 0.59% of Creative Medical Technology as of its most recent SEC filing. 1.42% of the stock is owned by institutional investors and hedge funds.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.